by nobilistx | Jul 26, 2021 | Uncategorized |
Portland, OR — Nobilis Therapeutics is happy to announce its participation in Biotechgate Digital Partnering event that will take place on August 30 Aug – 3 Sep, 2021. Biotechgate Digital Partnering is designed to support the business development of Pharma,...
by nobilistx | Jun 14, 2021 | Uncategorized |
An article in the April 15th issue of the Journal of Experimental Pharmacology titled “Experimental Drugs for Panic Disorder: An Updated Systematic Review” has devoted a significant section to the discussion of Nobilis Therapeutics’ approach to the...
by nobilistx | Jun 8, 2021 | Uncategorized |
Nobilis Therapeutics is looking forward to connecting with investors, biotechnology and pharma companies at the upcoming BIO Digital Conference. The company will be updating conference participants on its recent advancements and will be discussing investment...
by nobilistx | Dec 8, 2020 | Uncategorized |
As one of the few selected companies Nobilis Therapeutics had the opportunity to present its technology in front of over 100 sophisticated investors. While we didn’t win, our presentation and the Q&A session were very well received and have started a number...
by nobilistx | Nov 4, 2020 | Uncategorized |
PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) — Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will present at the virtual CapCon 2020 Venture Conference, Nov 16-17....
Recent Comments